AEG-41174 | MedKoo Biosciences

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

MedKoo product information:

AEG-41174

Description of AEG-41174: AEG-41174 is

Current developer: Aegera Therapeutics, Montreal, Canada.

MedKoo Code#: 200110
Name: AEG-41174
CAS#: Synonym: code name: AEG-41174 　 IUPAC/Chemical name:
Chemical structure	Theoretical analysis

Availability and price: This agent is not in stock. To inquire quotation and lead time or to ask questions, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

Information about this agent

AEG41174 is a novel, non-ATP competitive, small molecule tyrosine kinase inhibitor targeting therapeutically significant kinases including JAK2 and Bcr-Abl, and is currently in a Phase 1 clinical trial. (hematological malignancies)

References

Contact MedKoo:

Email: sales@medkoo.com

(Keyword; CAS#; MedKoo code#)